Newsfeeds - Spark Newswire

4 minute read

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank

Today, 9:10 AM

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the company’s Silicon Valley Bank.

AMBA

1 minute read

News

Eiger Biopharmaceuticals Says Co Has ~$8.3M, Or 6.9%, Of Cash With SVB

By Benzinga Newsdesk

Today, 9:10 AM

-SEC Filing

EIGR

3 minute read

Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 9:10 AM

Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.

AFRM

1 minute read

Eiger BioPharma’s Single Dose Of Peginterferon Lambda Cuts Risk Of COVID-19-Related Hospitalizations, Deaths

By Vandana Singh

Today, 9:10 AM

Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) announced the publication of data from the investigator-sponsored Phase 3 TOGETHER study in patients with COVID-19 in…

EIGR

2 minute read

Eiger BioPharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying

By Lisa Levin

Today, 9:10 AM

The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BMRA

1 minute read

Eiger BioPharmaceuticals Says On Jan. 3, 2023 Sriram Ryali Notified Co. Of Resignation As Chief Financial Officer Effective Jan. 20, 2023

By Michael Horton

Today, 9:10 AM

-SEC Filing

EIGR

2 minute read

Looking Into Eiger BioPharmaceuticals’s Recent Short Interest

By Benzinga Insights

Today, 9:10 AM

Eiger BioPharmaceuticals's (NASDAQ:EIGR) short percent of float has risen 8.06% since its last report. The company recently reported that it has 1.57 million shares sold short, which is 4.29% of all regular shares that are available for trading.

EIGR

2 minute read

Eiger BioPharmaceuticals Announced President and CEO David A. Cory Resigned; Dr. David Apelian Named Interim CEO

By Charles Gross

Today, 9:10 AM

Eiger BioPharmaceuticals, Inc. ("Eiger" or "the company") (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis delta virus (HDV) and other serious diseases, and its Board of Directors today announced that David A.

EIGR